| DAA905 |
Ability to secrete acid load decreases |
Physiological |
kidney |
Human |
— |
— |
|
| DAA269 |
alpha-kinase 2 |
Molecular |
kidney |
Human |
ALPK2 |
20.0% Increase Gene Expression Level |
|
| DAA267 |
amyloid beta (A4) precursor protein-binding, family B, member 1 interacting protein |
Molecular |
kidney |
Human |
APBB1IP |
23.0% Increase Gene Expression Level |
|
| DAA895 |
Basement membranes of glomeruli and tubules thicken |
Physiological |
renal tubule, glomerulus |
Human |
— |
— |
|
| DAA895 |
Basement membranes of glomeruli and tubules thicken |
Physiological |
renal tubule, glomerulus |
Human |
— |
— |
|
| DAA605 |
Bladder cancer |
Pathological |
bladder |
Human |
— |
SeriesMorbidity |
|
| DAA289 |
brain protein 44-like |
Molecular |
kidney |
Human |
BRP44L |
9.0% Decrease Gene Expression Level |
|
| DAA604 |
Cancer of kidney and renal pelvis |
Pathological |
urinary system |
Human |
— |
SeriesMorbidity |
|
| DAA291 |
chromosome 1 open reading frame 162 |
Molecular |
kidney |
Human |
C1orf162 |
37.0% Increase Gene Expression Level |
|
| DAA263 |
claudin 8 |
Molecular |
kidney |
Human |
CLDN8 |
17.0% Decrease Gene Expression Level |
|
| DAA281 |
coiled-coil domain containing 3 |
Molecular |
kidney |
Human |
CCDC3 |
19.0% Increase Gene Expression Level |
|
| DAA275 |
complement component 1, q subcomponent, C chain |
Molecular |
kidney |
Human |
C1QC |
27.0% Increase Gene Expression Level |
|
| DAA288 |
complement component 1, r subcomponent |
Molecular |
kidney |
Human |
C1R |
21.0% Increase Gene Expression Level |
|
| DAA265 |
complement component 1, s subcomponent |
Molecular |
kidney |
Human |
C1S |
24.0% Increase Gene Expression Level |
|
| DAA287 |
creatine kinase, brain |
Molecular |
kidney |
Human |
CKB |
10.0% Decrease Gene Expression Level |
|
| DAA1062 |
Creatinine clearance declines |
Physiological |
kidney |
Human |
— |
— |
|
| DAA273 |
cytoplasmic FMR1 interacting protein 2 |
Molecular |
kidney |
Human |
CYFIP2 |
11.0% Decrease Gene Expression Level |
|
| DAA272 |
dedicator of cytokinesis 11 |
Molecular |
kidney |
Human |
DOCK11 |
24.0% Increase Gene Expression Level |
|
| DAA256 |
defensin, beta 1 |
Molecular |
kidney |
Human |
DEFB1 |
8.0% Decrease Gene Expression Level |
|
| DAA881 |
Dietary protein required to induce renal sclerotic lesions decreases |
Physiological |
renal vasculature |
Human |
— |
— |
|
| DAA258 |
EF-hand domain family, member D1 |
Molecular |
kidney |
Human |
EFHD1 |
9.0% Decrease Gene Expression Level |
|
| DAA271 |
epidermal growth factor (beta-urogastrone) |
Molecular |
kidney |
Human |
EGF |
25.0% Decrease Gene Expression Level |
|
| DAA626 |
Essential (primary) hypertension and hypertensive renal disease |
Pathological |
heart, kidney |
Human |
— |
SeriesMorbidity |
|
| DAA280 |
FXYD domain containing ion transport regulator 2 |
Molecular |
kidney |
Human |
FXYD2 |
5.0% Decrease Gene Expression Level |
|
| DAA887 |
Glomerular filtration rate declines |
Physiological |
glomerulus |
Human |
— |
— |
|